I’m not Monday morning quarterbacking. I took the same position real-time over the past year. See my post 229067 and 225973. Back in May I called the P delay was due to not paying the CRO, rather than a known failed trail.
Of course, most trials fail, but they chose to not take a planned interim look on a drug the CEO had characterized as their “long shot” or something like that.
Market Data 
Markets 
AI
